Home › Precursor T-Cell Lymphoblastic Leukemia-Lymphoma › Washington
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma clinical trials in Washington, DC
5 studies for Precursor T-Cell Lymphoblastic Leukemia-Lymphoma are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma
RecruitingPhase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
RecruitingPhase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
RecruitingPhase 2
- Children's National Hospital, Washington D.C.
Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
RecruitingObservational studyHealthy volunteers welcome
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma
RecruitingPhase 1
- Children's National Medical Center, Washington D.C.
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma trials in other cities
- Houston, TX8 studies
- New York City, NY6 studies
- Columbus, OH5 studies
- Philadelphia, PA4 studies
- St. Louis, MO3 studies
- Queens, NY3 studies
- Staten Island, NY3 studies
- Edison, NJ3 studies
- East Norwalk, CT3 studies
- New Rochelle, NY3 studies
- Boston, MA3 studies
- Baldwin Park, CA3 studies
Other studies in Washington
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer55 studies
- Breast Cancer46 studies
- Metastatic Cancer43 studies
- Lung Cancer41 studies
- Prostate Cancer38 studies
- Obesity33 studies
- Colorectal Cancer29 studies
- Cardiovascular Disease28 studies
- Bladder Cancer26 studies
- Acute Myeloid Leukemia24 studies
- Ovarian Cancer23 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.